Company Filing History:
Years Active: 2019-2021
Title: Marxa L Figueiredo: Innovator in Anti-Cancer Research
Introduction
Marxa L Figueiredo is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of anti-cancer research, particularly focusing on compounds that target the laminin receptor.
Latest Patents
Figueiredo holds 2 patents, with his latest inventions being centered around a dock-derived compound against the laminin receptor 37LR. This innovative in silico screening method has generated compounds that exhibit anti-cancer functions in prostate cancer cell lines. A group of derivatives based on the hit compound from the in silico screening has been synthesized and tested, showing improved IC values that may have relevant clinical applications for prostate cancer or osteoarthritis.
Career Highlights
He is currently associated with the Purdue Research Foundation, where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for cancer treatment.
Collaborations
Figueiredo collaborates with esteemed colleagues such as Charles Samuel Umbaugh and Herman O Sintim, contributing to a dynamic research environment that fosters innovation.
Conclusion
Marxa L Figueiredo's work exemplifies the intersection of innovation and practical application in the fight against cancer. His contributions are paving the way for future advancements in medical research and treatment options.